Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trialTao Jiang, Shengxiang Ren, Jie Zhang et al.|Signal Transduction and Targeted Therapy|2021Cited by 94
Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathwayJingyuan Zhang, Jiarui Wu|Chinese Medicine|2025Cited by 4